期刊文献+

血浆N-末端脑钠肽前体水平与冠状动脉病变程度的关系 被引量:5

Association between plasma concentration of N-terminal pro-brain natriuretic peptide levels and the severity of coronary artery lesions
原文传递
导出
摘要 目的:观察不同程度冠状动脉(冠脉)病变患者的血浆N-末端脑钠肽前体(NT-proBNP)水平的变化,探讨血浆NT-proBNP水平与冠脉病变严重程度的关系。方法:入选180例均经冠脉造影术确诊冠心病的患者,根据冠脉病变的程度分为单支组、双支组、多支组;另选30例非冠心病者作对照组。测定各组血浆NT-proB-NP水平和左室射血分数。结果:对照组、单支、双支和多支组血浆NT-proBNP水平分别为(65.53±5.73)、(255.84±28.37)、(442.78±86.43)、(940.00±215.35)ng/L;各冠脉病变组的明显高于对照组(P<0.01),且随冠脉病变支数增加而增高。血浆NT-proBNP水平与冠脉病变血管支数(r=0.815,P<0.01)及冠脉造影Gensini积分(r=0.870,P<0.01)呈显著正相关,与LVEF(r=-0.215,P<0.05)呈负相关,多元逐步回归分析显示血浆NT-proBNP水平对冠脉病变程度有独立的预测价值。结论:血浆NT-proBNP水平可以反映冠脉病变程度。 Objective:To observe the different extent of coronary artery disease in patients with plasma NT-proBNP level of change,and to investigate the relationship between plasma NT-proBNP levels and severity of coronary artery lesion.Method:The total of 180 patients were enrolled in the study.All patients underwent coronary angiography and the severity of coronary artery lesions was estimated by coronary angiographic Gensini scores. Measured plasma NT-proBNP and LVEF.And 30 persons without CHD were selected as the control.Result:Plasma NT-proBNP level of coronary artery disease was significantly higher than that of control group(P〈0.01),and furthermore,the NT-proBNP levels increased with the seversity of the branch of coronary artery lesion.Plasma NT-proBNP level was significantly correlated with the narrow of coronary artery lesion(r=0.815,P〈0.01) and coronary angiography Gensini score(r=0.870,P〈0.01),and was correlated with LVEF(r=-0.215,P 0.05)negatively.Conclusion:This study shows that NT-proBNP levels are closely related to the clinical and angiographic extent of CAD and a high predictor of coronary artery lesion.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2010年第11期846-849,共4页 Journal of Clinical Cardiology
关键词 冠状动脉疾病 N-末端脑钠肽前体 血管成形术 经腔 经皮冠状动脉 coronary artery disease N-terminal pro-brain natriuretic peptide angioplasty transluminal percutaneous coronary
  • 相关文献

参考文献2

二级参考文献12

  • 1SUDOH T,KANGAWA K,MINAMINO N,et al.A new natriuretic peptide in porcine brain[J].Nature,1988,332:78 -81.
  • 2MAISEL A.B-type natriuretic peptide levels diagnostic and prognostic in congestive heart failure:What's next?[J].Circulation,2002,105:2328-2331.
  • 3PALAZZUOLI A,POLDERMANS D,CAPOBIANCO S,et al.Rise and fall of B-type natriuretic peptide levels in patients with coronary artery disease and normal left ventricular function after cardiac revascularization[J].Coron Artery Dis,2006,17:419-423.
  • 4KALRA P R,GOMMA A,DALY C,et al.Reduction in plasma concentrations of N terminal pro B type natriuretic peptide following percutaneous coronary intervention[J].Heart,2004,90:1334-1335.
  • 5KLINGE R,Jφrgensen,THAULOW E,et al.N-terminal proatrial natriuretic peptide in angina pectoris:impact of revascularization by angioplasty[J].Int J Cardiol,1999,68:1-8.
  • 6CANTOR W J,KIM H H,JOLLY S,et al.B-type natriuretic Peptide and serum unbound free Fatty Acid levels after contemporary percutaneous coronary intervention[J].J Invasive Cardiol,2008,20:186-188.
  • 7YILDIRIR A,ACIKEL S,ERTAN C,et al.Effects of lesion complexity on baseline and postprocedural B-type natriuretic peptide levels in patients undergoing percutaneous coronary interventions[J].Tex Heart Inst J,2007,34:282-289.
  • 8SCHIANO P,REVEL F,HEMERY Y,et al.Increased secretion of NT-proBNP immediately after percutaneous coronary intervention:about 90 cases[J].Ann Cardiol Angeiol (Paris),2007,56:117-121.
  • 9BONACA M P,WIVIOTT S D,SABATINE M S,et al.Hemodynamic significance of periprocedural myocardial injury assessed with N-terminal pro-B-type natriuretic peptide after percutaneous coronary intervention in patients with stable and unstable coronary artery disease (from the JUMBO-TIMI 26 Trial)[J].Am J Cardiol,2007,99:344-348.
  • 10HAMA N,ITOH H,SHIRAKAMI G,et al.Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction[J].Circulation,1995,92:1558-1564.

共引文献55

同被引文献62

  • 1黄伟光,韦建瑞,吴同果,陈思伟,孙爱华,梅克治.冠心病病人N端前脑钠肽检测的临床意义[J].岭南心血管病杂志,2007,13(5):337-339. 被引量:14
  • 2刘鲁娜,范艳慧,努尔巴哈提,韩艺辉,郭继东,刘丹.血氨基末端脑钠肽前体与冠心病患者冠状动脉病变程度的关系[J].农垦医学,2014,36(3):203-206. 被引量:2
  • 3刘梅林,李继敏,胡大一,马志敏,高霖,庞永正.心绞痛患者血浆N-proBNP水平的变化及其临床意义[J].中华心血管病杂志,2004,32(6):497-500. 被引量:66
  • 4Avanzas P,Arroyo ER,Cosin SJ,et al.Markers of inflammationand multiple complex stenoses(pancoronary plaque vulnerability)in patients with non-ST segment elevation acute coronarysyndromes[J].Heart,2004,90(8):847-852.
  • 5Patel V B,Robbins M A,Topol E J.C-reactiveprote in:agoldenmarker for inflammation and coronary artery disease[J].Cleve Clin J Med,2004,68(6):521-534.
  • 6Yong SK.Rosuvastatin Suppresses the Inflammatory ResponsesThrough Inhibition of c-Jun N-terminal Kinase and Nuclear Factor-κBin Endothelial Cells[J].J Cardiovasc Pharmacol,2007,49(6):376-383.
  • 7Marchesi C,Paradis P,Schiffrin EL.Role of the renin-angiotensinsystem invascular in flammat ion[J].Trend s Pha r macolSci,2008,29(7):367-374.
  • 8Skultet yova D,Filipova S,Riecansky I,et al.The role of angiotensintyp1 receptor in inflammation and endothelialdysfunction[J].Cardiovasc Drug Discov,2007,2(1):23-27.
  • 9Suzuki T, Yamazaki T, Yazaki Y. The roleof thenatriuretic peptide- sin thecardiovascular system. Cardiovsc Res, 2001,51 : 489-494.
  • 10Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation ,2002,105 ( 9 ) : 1135-1143.

引证文献5

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部